Please provide your email address to receive an email when new articles are posted on . During 4.7 years, 360 patients had 488 serious adverse reactions. More than 27% of serious reactions were ...

Fixed drug eruptions (FDEs) represent a distinctive subset of adverse drug reactions, characterised by the recurrence of lesions at identical anatomical sites with each exposure to the causative ...

Credit: Getty Images Cautious drug prescription and frequent drug monitoring are needed in patients with CKD, especially as kidney function declines, according to investigators. Given the elevated ...

Adverse drug reactions (ADRs) remain a significant challenge in pharmaceutical research and clinical practice. Increasingly, predictive models are being developed to forecast these undesirable effects ...

Of more than 100,000 suspected adverse drug reaction reports registered in EudraVigilance, most related to C difficile were associated with ciprofloxacin, ceftriaxone ...

In the United Kingdom, adverse drug reactions (ADRs) to cardiovascular drugs are very common, especially in older and sicker patients. Prevention may include educating patients, monitoring patient ...

Adverse drug reactions (ADRs) are a significant cause of hospital admissions and treatment discontinuation worldwide. Conventional approaches often fail to detect rare or delayed effects of medicinal ...

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a T-cell–mediated severe cutaneous adverse reaction characterized by rash, fever, internal organ involvement, and systemic ...

A new study explored the correlation between older, hospitalized women and adverse drug reactions. When hospitalized, 28% of women experienced one or more adverse drug reactions compared to 21% of men ...

Researchers from Queen Mary University of London (QMUL) found that 9% of all adverse drug reactions (ADRs) reported to the Yellow Card database are associated with medications where genetic factors ...

The number of serious adverse drug events (ADEs) reported to the FDA has more than doubled in recent years, according to a new analysis from the Institute for Safe Medication Practices.Between 1998 ...